Food Effect Phase I Study of the Sulfatinib in Healthy Subjects (HMPL-012)
Phase of Trial: Phase I
Latest Information Update: 16 Jul 2015
At a glance
- Drugs Sulfatinib (Primary)
- Indications Neuroendocrine tumours; Solid tumours
- Focus Pharmacokinetics
- Sponsors Hutchison MediPharma
- 13 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jan 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Dec 2014 New trial record